433 related articles for article (PubMed ID: 15073321)
41. Mutations in CRADD Result in Reduced Caspase-2-Mediated Neuronal Apoptosis and Cause Megalencephaly with a Rare Lissencephaly Variant.
Di Donato N; Jean YY; Maga AM; Krewson BD; Shupp AB; Avrutsky MI; Roy A; Collins S; Olds C; Willert RA; Czaja AM; Johnson R; Stover JA; Gottlieb S; Bartholdi D; Rauch A; Goldstein A; Boyd-Kyle V; Aldinger KA; Mirzaa GM; Nissen A; Brigatti KW; Puffenberger EG; Millen KJ; Strauss KA; Dobyns WB; Troy CM; Jinks RN
Am J Hum Genet; 2016 Nov; 99(5):1117-1129. PubMed ID: 27773430
[TBL] [Abstract][Full Text] [Related]
42. Structural features of caspase-activating complexes.
Park HH
Int J Mol Sci; 2012; 13(4):4807-4818. PubMed ID: 22606010
[TBL] [Abstract][Full Text] [Related]
43. Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade.
Droin N; Beauchemin M; Solary E; Bertrand R
Cancer Res; 2000 Dec; 60(24):7039-47. PubMed ID: 11156409
[TBL] [Abstract][Full Text] [Related]
44. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation.
Stehlik C; Lee SH; Dorfleutner A; Stassinopoulos A; Sagara J; Reed JC
J Immunol; 2003 Dec; 171(11):6154-63. PubMed ID: 14634131
[TBL] [Abstract][Full Text] [Related]
45. Involvement of Upregulated P53-Induced Death Domain Protein in Retinal Ganglion Cells Apoptosis After Optic Nerve Crush.
Zhang M; Chen L; Xu F; Jiang L; Yan W; Kunwar B; Tang F; Yang K; Shen C; Huang H; Lv J; Qin C; Wu X; Zeng S; Li M; Zhong S; Chen Q
Curr Mol Med; 2019; 20(1):51-59. PubMed ID: 31533600
[TBL] [Abstract][Full Text] [Related]
46. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization.
Lassus P; Opitz-Araya X; Lazebnik Y
Science; 2002 Aug; 297(5585):1352-4. PubMed ID: 12193789
[TBL] [Abstract][Full Text] [Related]
47. Iodine-131 induces apoptosis in human cardiac muscle cells through the p53/Bax/caspase-3 and PIDD/caspase-2/ t‑BID/cytochrome c/caspase-3 signaling pathway.
Wang Y; Liu C; Wang J; Zhang Y; Chen L
Oncol Rep; 2017 Sep; 38(3):1579-1586. PubMed ID: 28714021
[TBL] [Abstract][Full Text] [Related]
48. Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells.
Hopkins-Donaldson S; Yan P; Bourloud KB; Muhlethaler A; Bodmer JL; Gross N
Oncogene; 2002 Sep; 21(39):6132-7. PubMed ID: 12203125
[TBL] [Abstract][Full Text] [Related]
49. Total recall: the role of PIDDosome components in neurodegeneration.
Volik PI; Kopeina GS; Zhivotovsky B; Zamaraev AV
Trends Mol Med; 2023 Dec; 29(12):996-1013. PubMed ID: 37716905
[TBL] [Abstract][Full Text] [Related]
50. Flexible stoichiometry and asymmetry of the PIDDosome core complex by heteronuclear NMR spectroscopy and mass spectrometry.
Nematollahi LA; Garza-Garcia A; Bechara C; Esposito D; Morgner N; Robinson CV; Driscoll PC
J Mol Biol; 2015 Feb; 427(4):737-752. PubMed ID: 25528640
[TBL] [Abstract][Full Text] [Related]
51. DNA-PKcs-PIDDosome: a nuclear caspase-2-activating complex with role in G2/M checkpoint maintenance.
Shi M; Vivian CJ; Lee KJ; Ge C; Morotomi-Yano K; Manzl C; Bock F; Sato S; Tomomori-Sato C; Zhu R; Haug JS; Swanson SK; Washburn MP; Chen DJ; Chen BP; Villunger A; Florens L; Du C
Cell; 2009 Feb; 136(3):508-20. PubMed ID: 19203584
[TBL] [Abstract][Full Text] [Related]
52. p53 mediates DNA damaging drug-induced apoptosis through a caspase-9-dependent pathway in SH-SY5Y neuroblastoma cells.
Cui H; Schroering A; Ding HF
Mol Cancer Ther; 2002 Jul; 1(9):679-86. PubMed ID: 12479364
[TBL] [Abstract][Full Text] [Related]
53. The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis.
Imai Y; Kimura T; Murakami A; Yajima N; Sakamaki K; Yonehara S
Nature; 1999 Apr; 398(6730):777-85. PubMed ID: 10235259
[TBL] [Abstract][Full Text] [Related]
54. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
[TBL] [Abstract][Full Text] [Related]
55. Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation.
Chow KU; Nowak D; Boehrer S; Ruthardt M; Knau A; Hoelzer D; Mitrou PS; Weidmann E
Biochem Pharmacol; 2003 Sep; 66(5):711-24. PubMed ID: 12948851
[TBL] [Abstract][Full Text] [Related]
56. The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd.
Peintner L; Dorstyn L; Kumar S; Aneichyk T; Villunger A; Manzl C
Cell Death Differ; 2015 Nov; 22(11):1803-11. PubMed ID: 25857265
[TBL] [Abstract][Full Text] [Related]
57. RAIDD aggregation facilitates apoptotic death of PC12 cells and sympathetic neurons.
Jabado O; Wang Q; Rideout HJ; Yeasmin M; Guo KX; Vekrellis K; Papantonis S; Angelastro JM; Troy CM; Stefanis L
Cell Death Differ; 2004 Jun; 11(6):618-30. PubMed ID: 14765136
[TBL] [Abstract][Full Text] [Related]
58. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
Wang S; El-Deiry WS
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705
[TBL] [Abstract][Full Text] [Related]
59. An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells.
Morgan MJ; Thorburn J; Thomas L; Maxwell T; Brothman AR; Thorburn A
Cell Death Differ; 2001 Jul; 8(7):696-705. PubMed ID: 11464214
[TBL] [Abstract][Full Text] [Related]
60. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
